DocDollars

Genzyme Corporation

MA · United States · Reporting entity ID 100000000297

Total reported 2019–2025
$518.5M
#35 of 2,960 reporting companies — 0.6% of all reported industry payments
$296.1M in general payments across 884,853 records, plus $222.4M in research funding across 21,311 records.

How it breaks down

General payments $296,076,397
Research funding $222,386,761

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Genzyme Corporation reported $518.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #35 of 2,960 reporting companies. 43% of that was research funding and 57% general payments such as consulting, speaking, food and travel. 884,853 general payment records and 21,311 research records were filed.

Common questions about Genzyme Corporation

How much has Genzyme Corporation paid US doctors?

Genzyme Corporation reported $518,463,158 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $296,076,397 in general payments, $222,386,761 in research funding.

How does Genzyme Corporation rank among drug and device companies?

It ranks #35 of 2,960 reporting entities by total reported value, about 0.6% of all industry payments in the dataset.

Does a payment from Genzyme Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.